Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | MET | P08581 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.38 |
| ▸ | MTOR | P42345 | 2/20 | 0.38 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1103452 | 1.00 | KDM4E (0.43) | KDM4EGPR3METESR1ESR2 | |
| SCHEMBL1103446 | 0.98 | ESR1 (0.43) | KDM4EGPR3METESR1ESR2 | |
| SCHEMBL1103522 | 0.98 | KDM4E (0.42) | KDM4EGPR3METESR1ESR2 | |
| SCHEMBL1103375 | 0.98 | KDM4E (0.42) | KDM4EGPR3METESR1ESR2 | |
| SCHEMBL1103465 | 0.97 | ESR1 (0.42) | KDM4EGPR3METESR1ESR2 | |
| SCHEMBL1103381 | 0.96 | ESR1 (0.48) | KDM4EGPR3METESR1ESR2 | |
| SCHEMBL1103448 | 0.96 | ESR1 (0.48) | KDM4EGPR3METESR1ESR2 | |
| SCHEMBL1103484 | 0.96 | ESR1 (0.48) | KDM4EGPR3METESR1ESR2 | |
| SCHEMBL1103485 | 0.96 | ESR1 (0.48) | KDM4EGPR3METESR1ESR2 | |
| SCHEMBL1103493 | 0.96 | ESR1 (0.48) | KDM4EGPR3METESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10950803-B2 | Compounds and uses in devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-16 | — | — | US | disclosed |
| US-20190319194-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-10-17 | — | — | US | disclosed |
| US-20160149139-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-05-26 | — | — | US | disclosed |
| US-20160149139-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-05-26 | — | — | US | disclosed |
| US-20160104847-A1 | NOVEL COMPOUNDS AND USES IN DEVICES | UNIVERSAL DISPLAY CORPORATION | 2016-04-14 | — | — | US | disclosed |
| US-20160104847-A1 | NOVEL COMPOUNDS AND USES IN DEVICES | UNIVERSAL DISPLAY CORPORATION | 2016-04-14 | — | — | US | disclosed |
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| EP-2147962-A1 | Azaanthracene-derivatives and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2010-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, OCIAD2, OCIAD1 | KDM4E 3367/4885GPR3 1503/4885MET 4191/4885 |
| US-20160104847-A1 | NOVEL COMPOUNDS AND USES IN DEVICES | TERT, UACA, TXN | KDM4E 2066/4885GPR3 4018/4885MET 4668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.